HealthcareServices

Remote Irritable Bowel Syndrome (IBS) Monitoring Market Outlook 2026–2035: Growth Drivers and Industry Forecast

March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the remote irritable bowel syndrome (ibs) monitoring market from 2026–2035 with trusted insights from The Business Research Company

Across 2026–2030, what is the expected market valuation path of the Remote Irritable Bowel Syndrome (IBS) Monitoring Market?

The remote irritable bowel syndrome (ibs) monitoring market size has witnessed rapid expansion in recent years. Projections indicate it will grow from $1.4 billion in 2025 to $1.63 billion in 2026, achieving a compound annual growth rate (CAGR) of 16.0%. This historical growth can be attributed to the escalating prevalence of irritable bowel syndrome, the development of digital health platforms, the rising adoption of telehealth services, the broader availability of smartphone-based health monitoring, and the existence of cloud-based patient data systems.

The remote irritable bowel syndrome (ibs) monitoring market is projected to experience substantial expansion in the coming years. This market is anticipated to reach a valuation of $2.92 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 15.7%. The anticipated growth during this period stems from factors such as heightened demand for individualized gastrointestinal care, the expanding incorporation of remote diagnostic tools, the proliferation of value-based healthcare frameworks, the increasing application of predictive analytics in managing diseases, and increased funding for digital therapeutic solutions. Key trends projected for the forecast horizon encompass a rise in AI-powered symptom analysis, broader acceptance of mobile health monitoring platforms, greater incorporation of wearable IBS tracking devices, the development of customized treatment management instruments, and a stronger emphasis on patient involvement strategies.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=29175&type=smp

Which Drivers Are Supporting The Rise Of The Remote Irritable Bowel Syndrome (IBS) Monitoring Market?

The rising incidence of gastrointestinal disorders is projected to boost the expansion of the remote irritable bowel syndrome (IBS) monitoring market in the future. These conditions are ailments that disrupt the normal functioning of the digestive system, hindering digestion and bowel regularity. The surge in gastrointestinal disorders is primarily fueled by poor dietary choices that compromise gut health and digestion, leading to inflammation and digestive issues such as bloating and discomfort. Remote irritable bowel syndrome (IBS) monitoring helps alleviate symptom severity and slow the progression of the disease by enabling early detection of triggers and continuous management, thereby resulting in improved patient outcomes and an enhanced quality of life. For instance, in February 2025, according to Crohn’s & Colitis Australia, an Australia-based national organization, the anticipated prevalence of inflammatory bowel disease (IBD) in Australia is expected to climb from 20,511,881 cases in 2023 to 23,067,771 cases by 2030. Hence, the increasing occurrence of gastrointestinal disorders is a significant factor driving the growth of the remote irritable bowel syndrome (IBS) market.

What Segments Are Identified Within The Structure Of The Remote Irritable Bowel Syndrome (IBS) Monitoring Market?

The remote irritable bowel syndrome (ibs) monitoring market covered in this report is segmented –

1) By Component: Devices, Software, Services

2) By Application: Diagnosis, Symptom Tracking, Treatment Management, Patient Education, Other Applications

3) By End-User: Hospitals And Clinics, Homecare Settings, Research Institutes, Other End-Users

Subsegments:

1) By Devices: Wearable Monitoring Devices, Non-Wearable Monitoring Devices, Portable Monitoring Devices, Implantable Monitoring Devices

2) By Software: Data Analytics Software, Mobile Health Applications, Remote Monitoring Platforms, Cloud-Based Software Solutions

3) By Services: Teleconsultation Services, Data Management Services, Technical Support Services, Training And Education Services

What Long-Term Trends Are Expected To Shape The Future Of The Remote Irritable Bowel Syndrome (IBS) Monitoring Market?

Leading firms within the remote irritable bowel syndrome (IBS) monitoring market are concentrating on creating white-label or co-branded service models, aiming to utilize existing digital infrastructure and clinical support systems. Such a model allows healthcare providers to offer pre-built digital health solutions under their own brand, merging a trusted identity with established technology for quicker implementation, reduced expenses, and an uninterrupted patient journey. As an example, in May 2024, Salvo Health, a US-based digital gastrointestinal care company, introduced its inaugural remote patient monitoring (RPM) enablement specifically for gastrointestinal (GI) chronic conditions. This initiative provides a novel digital care alternative for conditions including IBS, GERD, dyspepsia, celiac disease, and SIBO, enabling GI practices to integrate remote monitoring with conventional in-person treatment. Through its white-label or co-branded model, Salvo supplies local GI providers with digital resources, clinical personnel, and home monitoring equipment, empowering them to monitor heart rate variability (HRV) and correlate it with patient diet, behavior, and symptoms, thereby enhancing chronic care results and operational efficiency.

Which Key Market Players Are Investing In Expansion And Innovation Within The Remote Irritable Bowel Syndrome (IBS) Monitoring Market?

Major companies operating in the remote irritable bowel syndrome (ibs) monitoring market are Indegene, Vivante Health, Thryve Health, Heali AI Corp., Mahana Therapeutics Inc., metaMe Health Inc., Seed Health, Ayble Health, Oshi health, Salvo Health Inc., modifyhealth Inc., Food marble, nerva health, MyGiHealth, Sun Genomics, Dietahealth, Dige Health, Nori health, Sequenex, Bowelle.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/remote-irritable-bowel-syndrome-ibs-monitoring-global-market-report

Which Regions Are Poised For Strategic Growth In The Remote Irritable Bowel Syndrome (IBS) Monitoring Market?

North America was the largest region in the remote irritable bowel syndrome (IBS) monitoring market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the remote irritable bowel syndrome (ibs) monitoring market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Remote Irritable Bowel Syndrome (IBS) Monitoring Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=29175&type=smp

Browse Through More Reports Similar to the Global Remote Irritable Bowel Syndrome (IBS) Monitoring Market 2026, By The Business Research Company

Inflammatory Bowel Disease Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/inflammatory-bowel-disease-treatment-global-market-report

Bowel Management Systems Market Report 2026

https://www.thebusinessresearchcompany.com/report/bowel-management-systems-global-market-report

Gastrointestinal Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/gastrointestinal-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795